Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes; Shiliang Li, Chun Qin, Shichao Cui, Hongling Xu, Fangshu Wu, Jiawei Wang, Mingbo Su, Xiaoyu Fang, Dan Li, Qian Jiao, Ming Zhang, Chunmei Xia, Lili Zhu, Rui Wang, Jia Li, Hualiang Jiang, Zhenjiang Zhao*, Jingya Li*, and Honglin Li*; J. Med. Chem., 2019, 62 (5), pp 2348–2361.
Xu, L.; Li, W.; Diao, Y.; Sun, H.; Li, H.; Zhu, L.; Zhou, H.; Zhao, Z.*, Synthesis, Design, and Structure(-)Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase. Molecules2018,23.
Li, S.; Xu, H.; Cui, S.; Wu, F.; Zhang, Y.; Su, M.; Gong, Y.; Qiu, S.; Jiao, Q.; Qin, C.; Shan, J.; Zhang, M.; Wang, J.; Yin, Q.; Xu, M.; Liu, X.; Wang, R.; Zhu, L.; Li, J.; Xu, Y.; Jiang, H.; Zhao, Z.*; Li, J.; Li, H., Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes. J Med Chem2016,59, 6772-90.
Zhou, W.; Li, S.; Lu, W.; Yuan, J.; Xu, Y.; Li, H.; Huang, J.; Zhao, Z.*, Isoindole-1,3-dione derivatives as RSK2 inhibitors: synthesis, molecular docking simulation and SAR analysis. Med. Chem. Commun. 2016,7, 292-296.
Li, S.; Luan, G.; Ren, X.; Song, W.; Xu, L.; Xu, M.; Zhu, J.; Dong, D.; Diao, Y.; Liu, X.; Zhu, L.; Wang, R.; Zhao, Z.*; Xu, Y.; Li, H., Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity. Scientific reports2015,5, 14836.
Yang, L.; Liu, W.; Mei, H.; Zhang, Y.; Yu, X.; Xu, Y.; Li, H.; Huang, J.; Zhao, Z.*, Synthesis and biological evaluation of pentanedioic acid derivatives as farnesyltransferase inhibitors. Med. Chem. Commun. 2015,6, 671-676.
Yuan, J.; Zhao, Z.*; Zhu, W.; Li, H.; Qian, X.; Xu, Y., New strategy for the synthesis of 2-phenylbenzimidazole derivatives with sodium perborate (SPB) as oxidant. Tetrahedron2013,69, 7026-7030.
Gao, R.; Liao, S.; Zhang, C.; Zhu, W.; Wang, L.; Huang, J.; Zhao, Z.*; Li, H.; Qian, X.; Xu, Y., Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship. European journal of medicinal chemistry2013,62, 597-604.
Zhong, Y.; Xue, M.; Zhao, X.; Yuan, J.; Liu, X.; Huang, J.; Zhao, Z.*; Li, H.; Xu, Y., Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis. Bioorganic & medicinal chemistry2013,21, 1724-34.
Xue, M.; Xu, M.; Lu, W.; Huang, J.; Li, H.; Xu, Y.; Liu, X.;Zhao, Z.*, Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors. J Enzyme Inhib Med Chem2013,28, 747-52.
